AVE 33.3% 0.2¢ avecho biotechnology limited

pohs next deal: demeratological drugs, page-68

  1. 1,534 Posts.
    lightbulb Created with Sketch. 57
    Hey Tland,

    As i have mentioned before, a member of the WL clan, has an involvement in the companion pet industry, and i ran it past them last week

    Whilst its up to Novartis to work up the patch and so on under the deal, patchs and skin bonded applications have been around the vet industry for year, so its a no brainer from that point of veiw

    On the smaller quadrapeds sometimes an elizabethan collar is needed but with POH's lower overall erythmia as outlined with all the TPM profiles, itching and scratching has not been a problem in humans so i suspect novartis would have checked this out before signing on the dotted line in that respect for a multi million dollar contract as they have done

    this is not a MTA, these guys have actually said they will pay us, i know thats a novel concept among some coys, but Novartis is a Billion dollar coy and they are paying for all the development costs

 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
(20min delay)
Last
0.2¢
Change
-0.001(33.3%)
Mkt cap ! $6.338M
Open High Low Value Volume
0.3¢ 0.3¢ 0.2¢ $17 5.798K

Buyers (Bids)

No. Vol. Price($)
55 95690716 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 59980558 19
View Market Depth
Last trade - 16.10pm 09/08/2024 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.